（文章来源：证券日报） 证券日报网讯 9月16日晚间，国药现代发布公告称，近日，公司全资子公司国药集团工业有限公司收到 国家药品监督管理局核准签发的盐酸戊乙奎醚注射液《药品注册证书》。 ...

Core Viewpoint - The company Guoyao Modern has received approval from the National Medical Products Administration for its product, "Pentazocine Hydrochloride Injection," which may enhance its market position and revenue potential in the pharmaceutical sector [1]. Company Summary - Guoyao Modern's subsidiary, Shanghai Modern Pharmaceutical Co., Ltd., has obtained a drug registration certificate for Pentazocine Hydrochloride Injection [1]. - As of the latest report, Guoyao Modern's market capitalization stands at 14.8 billion yuan [1]. Revenue Composition - For the year 2024, Guoyao Modern's revenue composition is as follows: - Formulations account for 49.84% - Intermediates and raw materials account for 47.53% - Other businesses account for 2.44% - Health-related products account for 0.19% [1].

国药现代9月16日公告，公司全资子公司国药集团工业有限公司收到国家药品监督管理局核准签发的盐 酸戊乙奎醚注射液《药品注册证书》。盐酸戊乙奎醚注射液为选择性抗胆碱药，主要用于麻醉前给药以 抑制唾液腺和气道腺体分泌，以及用于有机磷毒物（农药）中毒急救治疗和中毒后期或胆碱酯酶 （ChE）老化后维持阿托品化。本次国药工业的盐酸戊乙奎醚注射液（1ml:1mg）获得药品注册证书并 视同通过一致性评价，将进一步丰富公司产品群，有利于进一步增强公司的综合市场竞争力，为公司未 来发展带来积极影响。上述事项对公司目前经营业绩不会产生重大影响。因药品销售易受到行业政策、 招标采购、市场环境等因素影响，存在不确定性。 ...

Core Viewpoint - The approval of the drug registration certificate for the injection of Pentylquaternary Ammonium Hydrochloride by China National Pharmaceutical Group Modern Co., Ltd. is expected to enhance the company's product portfolio and market competitiveness, positively impacting future development [1] Group 1 - The injection of Pentylquaternary Ammonium Hydrochloride is a selective anticholinergic drug used for pre-anesthetic medication to suppress salivary and airway gland secretion, as well as for emergency treatment of organophosphate poisoning [1] - The product (1ml:1mg) has received the drug registration certificate from the National Medical Products Administration, which is considered equivalent to passing the consistency evaluation [1] - This approval will enrich the company's product offerings and strengthen its overall market competitiveness [1]